The results are presented in Fig 3: ET patients (183.0, 86.8–327.0) (n = 19) and MF patients (135.1, 73.01–247.6) (n = 28) had significantly elevated IGF-1R levels compared with controls (47.75, 34.50–68.79) (n = 30), and PV patients appeared to have more significantly elevated levels than did ET or MF patients. The gene discussed is IGF1R; the disease is acquired polycythemia vera.